Verrica Pharmaceuticals Inc. (VRCA) Free cash flow 2018–2025
Verrica Pharmaceuticals Inc. (VRCA) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$17.6MFY2025 · since FY2018: -$18.6M → -$17.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$17.6M | +71.1% |
| FY2024 | -$61.0M | -56.5% |
| FY2023 | -$38.9M | -105.5% |
| FY2022 | -$19.0M | +33.4% |
| FY2021 | -$28.5M | +10.1% |
| FY2020 | -$31.7M | -12.8% |
| FY2019 | -$28.1M | -50.6% |
| FY2018 | -$18.6M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More VRCA financial trends
VRCA RevenueVRCA Net incomeVRCA Net marginVRCA Gross profitVRCA Gross marginVRCA Operating incomeVRCA Operating marginVRCA Operating cash flowVRCA Capital expendituresVRCA Return on equityVRCA Stock buybacksVRCA Dividends paidVRCA Total assetsVRCA Total liabilitiesVRCA Shareholders’ equityVRCA overview →